From: Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
Virus
Peptide
Normalized activity (± SD)
Wild-type (HXB2)
ERQANFLGKIWPS
100 ± 5.0
436E + 437 T
ERQANFLGETWPS
240 ± 3.6
+435R
ERQANFLRETWPS
210 ± 18.9
+438R
ERQANFLGETRPS
160 ± 6.7